Bariatric surgery linked to reduced risk for skin cancer

October 31, 2019

(HealthDay)—For individuals with obesity, bariatric surgery is associated with a reduced risk for skin cancer, including melanoma, according to a study published online Oct. 30 in JAMA Dermatology.

Magdalena Taube, Ph.D., from the University of Gothenburg in Sweden, and colleagues examined the correlation of with and melanoma incidence in the Swedish Obese Subjects nonrandomized controlled trial. A total of 2,007 patients with who underwent bariatric surgery and 2,040 contemporaneous matched controls who received conventional obesity treatment were included; information on cancer events was available for 4,042 patients.

The researchers found that bariatric surgery was associated with significantly reduced risks for melanoma and skin cancer in general (adjusted subhazard ratios, 0.43 and 0.59, respectively). The reduction in skin cancer risk did not correlate with baseline body mass index or weight; insulin, glucose, lipid, and creatinine levels; diabetes; blood pressure; alcohol intake; or smoking.

"The has been accompanied by increased incidences of many serious diseases, including cancer," the authors write. "These findings suggest that melanoma incidence is significantly reduced in patients with obesity after bariatric surgery and may lead to a better understanding of melanoma and preventable risk factors."

Two authors disclosed financial ties to the pharmaceutical industry.

More information: Abstract/Full Text (subscription or payment may be required)

Journal information: JAMA Dermatology

Copyright © 2019 HealthDay. All rights reserved.